C07C 281/16
Compounds containing any of the groups [image cpc-sch-c07c-0974.gif]
Official title: Compounds containing any of the groups [IMAGE cpc-sch-C07C-0974.gif], e.g. aminoguanidine
C07C281/16 (Compounds containing any of the groups [image cpc-sch-c07c-0974.gif]) appears on 198 US grants and 118 published applications in this corpus.
Search patents in C07C- Granted patents
- 198
- Published applications
- 118
- Assignees
- 114
- Inventors
- 436
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 5 | 0 |
| 1978 | 9 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 1 | 0 |
| 1997 | 17 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 9 | 5 |
| 2002 | 5 | 5 |
| 2003 | 3 | 5 |
| 2004 | 3 | 5 |
| 2005 | 2 | 5 |
| 2006 | 4 | 5 |
| 2007 | 3 | 2 |
| 2008 | 1 | 4 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 7 |
| 2012 | 4 | 2 |
| 2013 | 3 | 5 |
| 2014 | 6 | 5 |
| 2015 | 1 | 2 |
| 2016 | 2 | 5 |
| 2017 | 7 | 11 |
| 2018 | 3 | 9 |
| 2019 | 7 | 6 |
| 2020 | 9 | 11 |
| 2021 | 7 | 1 |
| 2022 | 3 | 7 |
| 2023 | 3 | 1 |
| 2024 | 1 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- IGF2BP2 inhibitors and uses thereof31 Mar 2026US 12,590,056 B2City of Hope
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Antifungal compounds and methods of forming the same26 Dec 2023US 11,851,391 B2University of Kentucky Research Foundation
- Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof14 Nov 2023US 11,814,352 B2Jiangsu Kanion Pharmaceutical Co., Ltd.
- Methods for treating protozoan infections31 Jan 2023US 11,566,012 B2Neoculi Pty Ltd
- Igf2bp2 inhibitors and uses thereof27 Aug 2026US 2026/0250242 A1City of Hope
- Compositions, methods, and systems for the synthesis and use of imaging agents29 May 2025US 2025/0170282 A1Lantheus Medical Imaging, Inc.
- Biguanide derivative of ibuprofen and process of preparation thereof27 Feb 2025US 2025/0066289 A1BVDU's Poona College of Pharmacy
- Self-assembled active agents14 Nov 2024US 2024/0373854 A1
- Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications5 Sep 2024US 2024/0293343 A1Inflectis Bioscience
Most cited
By later US patents
- Guanylhydrazones and their use to treat inflammatory conditions94US 5,854,289 AThe Picower Institute for Medical Research · 1998
- Isolating aminoarginine and use to block nitric oxide formation in body58US 5,059,712 ACornell Research Foundation, Inc. · 1991
- N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body54US 5,132,453 ACornell Research Foundation, Inc. · 1992
- Therapeutic agents47US 4,060,640 AShell Oil Company · 1977
- Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers47US 5,403,861 ACambridge NeuroScience, Inc. · 1995